Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?

J Natl Cancer Inst. 2006 Sep 20;98(18):1261-3. doi: 10.1093/jnci/djj387.
No abstract available

Publication types

  • Comment
  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents, Hormonal / pharmacokinetics
  • Antineoplastic Agents, Hormonal / therapeutic use*
  • Aromatase Inhibitors / pharmacokinetics
  • Aromatase Inhibitors / therapeutic use*
  • Biomarkers, Tumor / analysis
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / metabolism
  • Breast Neoplasms / mortality
  • Estrogen Receptor Modulators / pharmacokinetics
  • Estrogen Receptor Modulators / therapeutic use*
  • Female
  • Humans
  • Meta-Analysis as Topic
  • Neoplasms, Hormone-Dependent / drug therapy*
  • Neoplasms, Hormone-Dependent / metabolism
  • Neoplasms, Hormone-Dependent / mortality
  • Polymorphism, Genetic
  • Randomized Controlled Trials as Topic
  • Survival Analysis
  • Tamoxifen / pharmacokinetics
  • Tamoxifen / therapeutic use*

Substances

  • Antineoplastic Agents, Hormonal
  • Aromatase Inhibitors
  • Biomarkers, Tumor
  • Estrogen Receptor Modulators
  • Tamoxifen